Table 1.
Patient characteristics (N = 43)
| Characteristics | Value |
|---|---|
| Age (years), mean ± SD | 61 ± 8.7 |
| Sex, n (%) | |
| Male | 31 (72.1) |
| Female | 12 (27.9) |
| Stage, n (%) | |
| Metastatic | 32 (74.4) |
| Unresectable recurrent | 11 (25.6) |
| Tumour location, n (%) | |
| Oropharynx | 13 (30.2) |
| Hypopharynx | 17 (39.5) |
| Larynx | 8 (18.6) |
| Metastatic sites | 5 (11.7) |
| HPV status (p16), n (%) | |
| Positive | 7 (31.8) |
| Negative | 15 (68.2) |
| PD‐L1 expression, 22C3, n (%) | |
| <1 | 5 (11.7) |
| 1 to <20 | 21 (48.8) |
| ≥20 | 17 (39.5) |
| PD‐L1 expression, SP263, n (%) | |
| <1 | 5 (11.7) |
| 1 to <20 | 20 (46.5) |
| ≥20 | 18 (41.8) |
HPV, human papillomavirus; PD‐L1, programmed death‐ligand 1; SD, standard deviation.